297 related articles for article (PubMed ID: 12887053)
1. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
Bode W; Maskos K
Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
[TBL] [Abstract][Full Text] [Related]
2. Structural properties of matrix metalloproteinases.
Bode W; Fernandez-Catalan C; Tschesche H; Grams F; Nagase H; Maskos K
Cell Mol Life Sci; 1999 Apr; 55(4):639-52. PubMed ID: 10357232
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
Bourboulia D; Stetler-Stevenson WG
Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
[TBL] [Abstract][Full Text] [Related]
4. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
5. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
[TBL] [Abstract][Full Text] [Related]
6. The structure of the catalytic domain of Tannerella forsythia karilysin reveals it is a bacterial xenologue of animal matrix metalloproteinases.
Cerdà-Costa N; Guevara T; Karim AY; Ksiazek M; Nguyen KA; Arolas JL; Potempa J; Gomis-Rüth FX
Mol Microbiol; 2011 Jan; 79(1):119-32. PubMed ID: 21166898
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.
Opdenakker G; Abu El-Asrar A
Cell Mol Life Sci; 2019 Aug; 76(16):3157-3166. PubMed ID: 31183508
[TBL] [Abstract][Full Text] [Related]
8. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.
Wright JW; Harding JW
Neural Plast; 2009; 2009():579382. PubMed ID: 20169175
[TBL] [Abstract][Full Text] [Related]
9. MMPs in learning and memory and neuropsychiatric disorders.
Beroun A; Mitra S; Michaluk P; Pijet B; Stefaniuk M; Kaczmarek L
Cell Mol Life Sci; 2019 Aug; 76(16):3207-3228. PubMed ID: 31172215
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases at a glance.
Hey S; Linder S
J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38236162
[TBL] [Abstract][Full Text] [Related]
11. Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.
Galea CA; Nguyen HM; George Chandy K; Smith BJ; Norton RS
Cell Mol Life Sci; 2014 Apr; 71(7):1191-210. PubMed ID: 23912897
[TBL] [Abstract][Full Text] [Related]
12. Cirrhosis: new research provides a basis for rational and targeted treatments.
Iredale JP
BMJ; 2003 Jul; 327(7407):143-7. PubMed ID: 12869458
[TBL] [Abstract][Full Text] [Related]
13. Engineering metalloproteinase inhibitors: tissue inhibitors of metalloproteinases or antibodies, that is the question.
Kalantar M; Hilpert GA; Mosca ER; Raeeszadeh-Sarmazdeh M
Curr Opin Biotechnol; 2024 Apr; 86():103094. PubMed ID: 38430575
[TBL] [Abstract][Full Text] [Related]
14. Whether reactive oxygen species plays a critical role in intrinsic (mitochondrial) pathway-mediated apoptosis in notochordal cells under high glucose concentrations?
Yang L; Zhu L; Cao Y; Wang K
Int Orthop; 2013 Aug; 37(8):1649-50. PubMed ID: 23740409
[No Abstract] [Full Text] [Related]
15. Metalloproteinases as Biomarkers and Sociomarkers in Human Health and Disease.
Costa D; Scalise E; Ielapi N; Bracale UM; Andreucci M; Serra R
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254696
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
Maskos K; Bode W
Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of matrix metalloproteinases and TIMPs.
Nagase H; Visse R; Murphy G
Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
[TBL] [Abstract][Full Text] [Related]
18. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.
Snoek-van Beurden PA; Von den Hoff JW
Biotechniques; 2005 Jan; 38(1):73-83. PubMed ID: 15679089
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
20. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
